These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2642032)

  • 21. [Chiral switch: pure enantiomers of drugs instead of racemic mixtures].
    Valentová J; Hutt AJ
    Ceska Slov Farm; 2004 Nov; 53(6):285-93. PubMed ID: 15630994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An introduction to enantiomers in psychopharmacology.
    Leonard BE
    Hum Psychopharmacol; 2001 Dec; 16(S2):S79-S84. PubMed ID: 12404712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nightmare of FDA clearance/approval to market: perception or reality?
    Tylenda CA
    Technol Health Care; 1996 Sep; 4(3):259-67. PubMed ID: 8931236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidance for industry on Population Pharmacokinetics; availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Feb; 64(27):6663-4. PubMed ID: 10557596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized drugs: current regulatory perspective.
    Chew N
    Respir Care; 2000 Jun; 45(6):764-8. PubMed ID: 10894466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 30. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR; Temple R
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New prescription for drug regulation.
    Pines WL
    FDA Consum; 1978 Jun; 12(5):7-10. PubMed ID: 10308117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(239):58942-60. PubMed ID: 10123232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canadian and US drug approval times and safety considerations.
    Rawson NS; Kaitin KI
    Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and approval of vaccines in the United States.
    Botstein P
    Isr J Med Sci; 1986; 22(3-4):268-71. PubMed ID: 3528047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics: regulatory aspects. Point of view of FDA.
    Teske RH; Newkirk DR
    Vet Hum Toxicol; 1990 Jun; 32(3):261-2. PubMed ID: 2353440
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of the Food and Drug Administration in the regulation of the products of recombinant DNA technology.
    Goldberg M; Miller HI
    Recomb DNA Tech Bull; 1981 Apr; 4(1):15-8. PubMed ID: 7255754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M
    Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract]   [Full Text] [Related]  

  • 40. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.